Aurora Cannabis

Canada’s dried flower exports have seen impressive growth, doubling year-over-year in 3Q24, with the sector hitting record levels in October. According to Pablo Zuanic, senior analyst at Zuanic & Associates, “The strong growth in dried flower exports signals a thriving international...

Cannabis stocks have faced significant challenges recently, driven by political uncertainty that has further weighed on a sector still struggling to regain its footing since the overhyped all-time highs of 2021. To help investors navigate the long-term outlook for key cannabis companies, we are...

Aurora Cannabis Inc. (NASDAQ:ACB) recently reported strong quarterly earnings that outpaced market expectations, despite a downturn across the cannabis sector.  Aurora's share price fell 18% following the earnings report, reflecting broader sector pressures, with the MSOS ETF down 29%. As of...

Cannabis stocks are showing signs of recovery, with several major players gaining momentum on Friday. NASDAQ-listed Canopy Growth (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), SNDL (NASDAQ:SNDL) and OrganiGram Holdings (NASDAQ:OGI), among others, are all seeing upward trends in their...

Several cannabis companies faced financial challenges in 2024, with some being delisted or under threat of delisting from major stock exchanges due to financial instability, low values, compliance issues and a turbulent market. This article looks into some of the key players that faced delisting,...

In a dramatic turn, Aurora Cannabis (NASDAQ:ACB) announced its breakup with Uruguay, closing operations by the end of September 2024. Acquired for $263 million in 2018, Aurora’s exit underscores a harsh reality: the market failed to meet its criteria for future growth, dashing hopes of...

Aurora Cannabis Inc. (NASDAQ:ACB) has partnered with Vectura Fertin Pharma, Inc. to launch a CBD lozenge in the form of a dissolvable tablet that delivers the precise dose of cannabidiol (CBD). The new product is expected to enhance patient care by providing an alternative consumption method...

Aurora Cannabis (NASDAQ:ACB) saw its international sales for the first half of 2024 reach C$39.3 million ($28.9 million), reflecting a 31% year-over-year increase. This growth includes the full acquisition of MedReleaf Australia in February 2024, which contributed significantly to the sales boost....

A short squeeze forces investors betting on a stock's decline (short sellers) to buy back shares at a higher price to avoid losses, triggering a price surge. Analyst Faizan Farooque sees this potential in Aurora Cannabis (NASDAQ: ACB) and Beyond Meat (NASDAQ: BYND) due to their recent actions...

This article is part of Benzinga Cannabis’ series ‘Cultivator Chronicles,’ which focuses on the latest trends, developments, and major players in the industry. Stay tuned as we dig into the world of cannabis growers and their contributions to this rapidly expanding market. The...

At the close of trading on Wednesday, the Dow Jones Industrial Average declined by 0.1% to reach 39,127.14, while the S&P 500 saw a comparable increase, rising to 5,211.49. Similarly, the Nasdaq finished in positive territory, gaining 0.2% to reach 16,227.46. These are the top stocks that...

Aurora Cannabis (TSE: ACB) is a company that operates within the cannabis industry, producing and distributing both medical and consumer cannabis products. They have a diverse portfolio of brands, including Aurora Drift, San Rafael '71, Daily Special, Whistler, and many others. In addition to their...

Canada's cannabis industry is about to hit C$6 billion (nearly $4.4 billion) in retail sales. In its latest report, analysis firm Z&A looks into the thriving year-on-year surge in recreational sales and the worrisome downturn in the medical marijuana sector. The report...

“Marijuana is different, that actually really did help me,” Prince Harry told physician and author Dr. Gabor Maté on Saturday in a widely viewed live-stream interview about the importance of personal healing. The Duke of Sussex opened up about his drug use in the...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), reported its financial and operational results late Thursday for the fiscal second quarter that ended December 31, 2022. "Following a tremendous effort to realize approximately $340 million of total annualized savings since February 2020...